These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36618000)

  • 1. Accuracy of aMMP-8 point-of-care test in indicating periodontal treatment outcomes in stage III/IV periodontitis: A 24-week follow-up study.
    Yilmaz M; Sorsa T; Demir E; Gürsoy M; Suominen A; Tervahartiala T; Räisänen IT; Gürsoy UK
    J Periodontal Res; 2023 Apr; 58(2):325-335. PubMed ID: 36618000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a novel point-of-care test for active matrix metalloproteinase-8: agreement between qualitative and quantitative measurements and relation to periodontal inflammation.
    Lorenz K; Keller T; Noack B; Freitag A; Netuschil L; Hoffmann T
    J Periodontal Res; 2017 Apr; 52(2):277-284. PubMed ID: 27214099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Comparative Analysis of Treatment-Related Changes in the Diagnostic Biomarker Active Metalloproteinase-8 Levels in Patients with Periodontitis.
    Keskin M; Rintamarttunen J; Gülçiçek E; Räisänen IT; Gupta S; Tervahartiala T; Pätilä T; Sorsa T
    Diagnostics (Basel); 2023 Feb; 13(5):. PubMed ID: 36900047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of a point-of-care aMMP-8 test in the discrimination of periodontal health and disease.
    Deng K; Pelekos G; Jin L; Tonetti MS
    J Clin Periodontol; 2021 Aug; 48(8):1051-1065. PubMed ID: 33998040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of active matrix metalloproteinase-8 point-of-care test for the discrimination of periodontal health status: Comparison of saliva and oral rinse samples.
    Deng K; Wei S; Xu M; Shi J; Lai H; Tonetti MS
    J Periodontal Res; 2022 Aug; 57(4):768-779. PubMed ID: 35575900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of active matrix metalloproteinase-8 (aMMP-8) chair-side test as a diagnostic biomarker in the staging of periodontal diseases.
    Öztürk VÖ; Emingil G; Umeizudike K; Tervahartiala T; Gieselmann DR; Maier K; Köse T; Sorsa T; Alassiri S
    Arch Oral Biol; 2021 Apr; 124():104955. PubMed ID: 33556789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A point-of-care test of active matrix metalloproteinase-8 predicts triggering receptor expressed on myeloid cells-1 (TREM-1) levels in saliva.
    Räisänen IT; Heikkinen AM; Pakbaznejad Esmaeili E; Tervahartiala T; Pajukanta R; Silbereisen A; Bostanci N; Sorsa T
    J Periodontol; 2020 Jan; 91(1):102-109. PubMed ID: 31343739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active Matrix Metalloproteinase-8 Point-of-Care (PoC)/Chairside Mouthrinse Test vs. Bleeding on Probing in Diagnosing Subclinical Periodontitis in Adolescents.
    Räisänen IT; Sorsa T; van der Schoor GJ; Tervahartiala T; van der Schoor P; Gieselmann DR; Heikkinen AM
    Diagnostics (Basel); 2019 Mar; 9(1):. PubMed ID: 30909530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active matrix metalloproteinase-8 (aMMP-8) point-of-care test (POCT) in the COVID-19 pandemic.
    Sorsa T; Sahni V; Buduneli N; Gupta S; Räisänen IT; Golub LM; Lee HM; Pätilä T; Bostanci N; Meurman J; Pärnänen P; Nwhator SO; Singla M; Gauba K
    Expert Rev Proteomics; 2021 Aug; 18(8):707-717. PubMed ID: 34468272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing of aMMP-8 point-of-care test with a modified new disease classification in Finnish adolescent cohorts.
    Heikkinen AM; Raivisto T; Räisänen I; Tervahartiala T; Bostanci N; Sorsa T
    Clin Exp Dent Res; 2022 Oct; 8(5):1142-1148. PubMed ID: 35676762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.
    Gupta S; Mohindra R; Singla M; Khera S; Kumar A; Rathnayake N; Sorsa T; Pfützner A; Räisänen IT; Soni RK; Kanta P; Jain A; Gauba K; Goyal K; Singh MP; Ghosh A; Kajal K; Mahajan V; Suri V; Bhalla A
    Clin Exp Dent Res; 2022 Aug; 8(4):988-1001. PubMed ID: 35818743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between serum and oral matrix metalloproteinase-8 levels and periodontal health status.
    Noack B; Kipping T; Tervahartiala T; Sorsa T; Hoffmann T; Lorenz K
    J Periodontal Res; 2017 Oct; 52(5):824-831. PubMed ID: 28345244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-8 levels in oral samples as a biomarker for periodontitis in the Chinese population: an observational study.
    Yuan C; Liu X; Zheng S
    BMC Oral Health; 2018 Mar; 18(1):51. PubMed ID: 29587716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local and systemic levels of aMMP-8 in gingivitis and stage 3 grade C periodontitis.
    Keles Yucel ZP; Afacan B; Emingil G; Tervahartiala T; Kose T; Sorsa T
    J Periodontal Res; 2020 Dec; 55(6):887-894. PubMed ID: 32790178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active MMP-8 point-of-care (PoC)/chairside enzyme-test as an adjunctive tool for early and real-time diagnosis of peri-implantitis.
    Lähteenmäki H; Tervahartiala T; Räisänen IT; Pärnänen P; Mauramo M; Gupta S; Sampson V; Rathnayake N; Heikkinen AM; Alassiri S; Gieselmann DR; Frankenberger R; Sorsa T
    Clin Exp Dent Res; 2022 Apr; 8(2):485-496. PubMed ID: 35118828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Point-of-Care/Chairside aMMP-8 Analytics of Periodontal Diseases' Activity and Episodic Progression.
    Räisänen IT; Heikkinen AM; Siren E; Tervahartiala T; Gieselmann DR; van der Schoor GJ; van der Schoor P; Sorsa T
    Diagnostics (Basel); 2018 Oct; 8(4):. PubMed ID: 30360358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active MMP-8 (aMMP-8) as a Grading and Staging Biomarker in the Periodontitis Classification.
    Sorsa T; Alassiri S; Grigoriadis A; Räisänen IT; Pärnänen P; Nwhator SO; Gieselmann DR; Sakellari D
    Diagnostics (Basel); 2020 Jan; 10(2):. PubMed ID: 31979091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of matrix metalloproteinase-8 biosensor, IFMA, and ELISA immunoassays to differentiate between periodontal health, gingivitis, and periodontitis.
    Umeizudike KA; Lähteenmäki H; Räisänen IT; Taylor JJ; Preshaw PM; Bissett SM; Tervahartiala T; O Nwhator S; Pärnänen P; Sorsa T
    J Periodontal Res; 2022 Jun; 57(3):558-567. PubMed ID: 35304757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of chairside salivary aMMP-8 findings with periodontal risk assessment parameters in patients receiving supportive periodontal therapy.
    Schmalz G; Kummer MK; Kottmann T; Rinke S; Haak R; Krause F; Schmidt J; Ziebolz D
    J Periodontal Implant Sci; 2018 Aug; 48(4):251-260. PubMed ID: 30202608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active matrix metalloproteinase-8 and interleukin-6 detect periodontal degeneration caused by radiotherapy of head and neck cancer: a pilot study.
    Keskin M; Lähteenmäki H; Rathnayake N; Räisänen IT; Tervahartiala T; Pärnänen P; Şenışık AM; Karaçetin D; Yentek Balkanay A; Heikkilä P; Hagström J; Rautava J; Haglund C; Gursoy UK; Silbereisen A; Bostanci N; Sorsa T
    Expert Rev Proteomics; 2020 Oct; 17(10):777-784. PubMed ID: 33406924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.